carboplatin,durvalumab,gemcitabine,paclitaxel,vinorelbine,cisplatin,nivolumab,docetaxel,pemetrexed,ipilimumab,pembrolizumab
astrazeneca,merck,bms
['kn 671', 'aegean', 'cm 816', 'nsclc', 'sclc']
based on the cm 816, aegean and now kn 671, for stage 2/3 resectable nsclc with no genomic alterations, do you give: #asco23
Professor and thoracic oncologist, Vice Chair Clinical Research @ClevelandClinic TCI, @ASCO #EdBook Editor in Chief, Dad, Steelers fan. All opinions mine. #LCSM